Table 4 Multivariate analysis of factors prognostic of survival in patients with gastric gastrointestinal stromal tumor (GIST) and synchronous gastric cancer
From: Prognostic analysis of gastric gastrointestinal stromal tumor with synchronous gastric cancer
Parameters | β | SE | Wald | P* | RR | 95% CI |
|---|---|---|---|---|---|---|
Age | −0.596 | 0.481 | 1.531 |  | 0.551 | 0.215-1.416 |
Synchronous gastric cancer | −2.296 | 0.602 | 14.571 | 0.000* | 0.101 | 0.031-0.327 |
Risk stratification | Â | Â | 24.190 | 0.000* | Â | Â |
Very low versus high | −2.504 | 0.607 | 17.001 | 0.000* | 0.082 | 0.025-0.269 |
Low versus high | −2.544 | 0.682 | 13.895 | 0.000* | 0.079 | 0.021-0.299 |
Intermediate versus high | −2.638 | 1.060 | 6.191 | 0.013* | 0.071 | 0.009-0.571 |
Postoperative oral imatinib | 2.213 | 1.045 | 4.489 | 0.034* | 9.146 | 1.180-70.864 |